Editors' ChoiceMelanoma

Measuring Metastatic Melanoma's Risk

See allHide authors and affiliations

Science Translational Medicine  09 Dec 2009:
Vol. 1, Issue 10, pp. 10ec38
DOI: 10.1126/scitranslmed.3000683

You are currently viewing the summary.

View Full Text

Summary

Patients with melanomas that express more immune-related genes and show less cell division have a better chance of survival.